Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 30, 2019

SELL
$14.75 - $17.26 $25,222 - $29,514
-1,710 Closed
0 $0
Q4 2018

Jun 12, 2019

BUY
$13.33 - $18.66 $22,794 - $31,908
1,710 New
1,710 $25,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.38B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track First National Corp Portfolio

Follow First National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.